Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (986)
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
385
Price
$90.10
Total Value
$34.69K
Shares Held After
674,956
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,750
Price
$90.10
Total Value
$247.77K
Shares Held After
3,899,917
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,200
Price
$89.95
Total Value
$197.89K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
1,300
Price
$90.00
Total Value
$117.00K
Shares Held After
61,202
% of Holdings
2.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
4
Price
$171.19
Total Value
$684.76
Shares Held After
15,666
% of Holdings
0.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
8
Price
$170.76
Total Value
$1.37K
Shares Held After
15,670
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
68
Price
$169.15
Total Value
$11.50K
Shares Held After
15,678
% of Holdings
0.4%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
537
Price
$168.64
Total Value
$90.56K
Shares Held After
15,746
% of Holdings
3.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
383
Price
$167.58
Total Value
$64.18K
Shares Held After
16,283
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
327
Price
$584.24
Total Value
$191.05K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
202
Price
$583.41
Total Value
$117.85K
Shares Held After
40,840
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,624
Price
$582.05
Total Value
$945.25K
Shares Held After
41,042
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,819
Price
$581.05
Total Value
$1.64M
Shares Held After
42,666
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,255
Price
$580.02
Total Value
$1.31M
Shares Held After
45,485
% of Holdings
4.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
684
Price
$579.14
Total Value
$396.13K
Shares Held After
47,740
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
629
Price
$577.81
Total Value
$363.44K
Shares Held After
48,424
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
880
Price
$576.98
Total Value
$507.74K
Shares Held After
49,053
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$575.29
Total Value
$46.02K
Shares Held After
49,933
% of Holdings
0.2%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
92,554
Price
$0.76
Total Value
$70.34K
Shares Held After
197,052
% of Holdings
47.0%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
1,018
Price
$42.61
Total Value
$43.38K
Shares Held After
111,473
% of Holdings
0.9%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
1,014
Price
$42.61
Total Value
$43.21K
Shares Held After
116,899
% of Holdings
0.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$27.66
Total Value
$175.59K
Shares Held After
69,792
% of Holdings
8.3%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
1,559
Price
$42.53
Total Value
$66.30K
Shares Held After
105,211
% of Holdings
1.5%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
5,226
Price
$41.62
Total Value
$217.51K
Shares Held After
106,770
% of Holdings
4.7%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
20
Price
$42.66
Total Value
$853.20
Shares Held After
432,886
% of Holdings
0.0%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
7,165
Price
$41.75
Total Value
$299.14K
Shares Held After
432,906
% of Holdings
1.6%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
56,815
Price
$41.01
Total Value
$2.33M
Shares Held After
440,071
% of Holdings
11.4%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
500
Price
$67.38
Total Value
$33.69K
Shares Held After
33,377
% of Holdings
1.5%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,273
Price
$66.56
Total Value
$151.30K
Shares Held After
33,877
% of Holdings
6.3%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
4,227
Price
$65.73
Total Value
$277.84K
Shares Held After
36,150
% of Holdings
10.5%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$65.38
Total Value
$490.35K
Shares Held After
415,330
% of Holdings
1.8%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
7,449
Price
$66.02
Total Value
$491.78K
Shares Held After
58,555
% of Holdings
11.3%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
53,644
Price
$16.01
Total Value
$858.84K
Shares Held After
3,197,619
% of Holdings
1.6%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
3,300
Price
$40.00
Total Value
$132.00K
Shares Held After
1,491,934
% of Holdings
0.2%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
3,000
Price
$40.00
Total Value
$120.00K
Shares Held After
405,775
% of Holdings
0.7%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.56
Total Value
$277.51K
Shares Held After
416,836
% of Holdings
4.4%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
47,814
Price
$44.51
Total Value
$2.13M
Shares Held After
3,482,888
% of Holdings
1.4%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
47,814
Price
$44.51
Total Value
$2.13M
Shares Held After
3,482,888
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
4,159
Price
$89.97
Total Value
$374.19K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
5,251
Price
$90.00
Total Value
$472.60K
Shares Held After
61,202
% of Holdings
7.9%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
1,347
Price
$90.00
Total Value
$121.23K
Shares Held After
50,195
% of Holdings
2.6%
Travere Therapeutics, Inc. (TVTX)
LYONS GARY A — Director
Shares
8,000
Price
$41.07
Total Value
$328.56K
Shares Held After
57,500
% of Holdings
12.2%
Travere Therapeutics, Inc. (TVTX)
Calvin Sandra — SVP, CHIEF ACCOUNTING OFFICER
Shares
21,977
Price
$41.07
Total Value
$902.60K
Shares Held After
42,353
% of Holdings
34.2%
Travere Therapeutics, Inc. (TVTX)
Baynes Roy D. — Director
Shares
6,750
Price
$42.12
Total Value
$284.31K
Shares Held After
37,500
% of Holdings
15.3%
Travere Therapeutics, Inc. (TVTX)
Baynes Roy D. — Director
Shares
26,000
Price
$41.07
Total Value
$1.07M
Shares Held After
44,250
% of Holdings
37.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
957
Price
$581.50
Total Value
$556.50K
Shares Held After
40,513
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,675
Price
$580.55
Total Value
$2.13M
Shares Held After
41,470
% of Holdings
8.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,580
Price
$579.65
Total Value
$915.84K
Shares Held After
45,145
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,164
Price
$578.41
Total Value
$673.27K
Shares Held After
46,725
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,360
Price
$577.62
Total Value
$785.57K
Shares Held After
47,889
% of Holdings
2.8%
Showing 251–300 of 986 transactions (page 6 of 20)